New drug candidate prevents preterm birth in preclinical studies
Peer-Reviewed Publication
Updates every hour. Last Updated: 6-Jun-2026 13:16 ET (6-Jun-2026 17:16 GMT/UTC)
Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical model. The current standard treatment for preterm labor, Nifedipine, failed to confer similar benefits. The researchers plan to begin clinical trials as Rytvela represents a promising treatment approach to safely prolong pregnancy and fetal growth while allowing newborn organs to continue developing in utero.
- uOttawa multidisciplinary team has built new hydrogels from synthetic peptides that can be customized as needed - a defining hallmark in the emerging era of personalized medicine. - Offers game-changing potential to impact future biomedical applications, from sealing traumatic wounds to closing surgical incisions. - Bonding strength is comparable to commercially available tissue adhesives.
Having a dog, cat or other pet can help older adults stay active and maintain a sense of purpose, but pet-related costs may increasingly strain their budgets, a new poll suggests.
Schizophrenia is a complex psychiatric disorder involving disruptions in neurotransmitters, neurodevelopment, immune function, and genetics. While current antipsychotics mainly target dopamine, they often fail to address negative and cognitive symptoms. This review synthesizes the latest findings on the pathophysiology of schizophrenia and highlights emerging treatments such as TAAR1 agonists, muscarinic modulators, NMDA enhancers, anti-inflammatory agents, and gut-brain axis interventions, paving the way for more precise and effective therapies.
Recently, the research team led by Prof. Youqiong Ye at the Shanghai Institute of Immunology published a comprehensive review entitled “Mapping Biology in Space: From Spatial Transcriptomics Platforms to Analytical Tools and Databases” in Science Bulletin.The review summarizes the key challenges currently facing the field of spatial transcriptomics and outlines future directions for its development. In addition, the authors developed SpatialToolDB (https://www.spatialtooldb.yelab.site/), a systematically curated, classified, and continuously updated database that currently catalogs 77 spatial transcriptomics technologies and 594 spatial transcriptomics analysis tools.By integrating the existing analytical tool ecosystem and providing an interactive resource portal, this review and SpatialToolDB offer a data-driven foundation to support researchers in selecting appropriate spatial transcriptomics platforms and analytical methods across diverse biological and translational research contexts.
Biodiversity is changing across the planet, yet governments still lack the robust, consistent data needed to track these changes and guide effective conservation. Now, a new study led by the University of Amsterdam (UvA), the German Centre for Integrative Biodiversity Research (iDiv), and the Martin Luther University Halle-Wittenberg (MLU), proposes a comprehensive roadmap to build a modern, integrated Biodiversity Observation Network (BON) for Europe – one that could become a global model for biodiversity monitoring in the 21st century. The study has been published in the journal Nature Reviews Biodiversity.